The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.
from NDTV News - Special https://ift.tt/2FN96yE
Subscribe to:
Post Comments (Atom)
Core sector output slows to 2.3% in February; crude, gas and refinery drag weighs on momentum
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/IqLBfrM
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
The European Central Bank's October meeting minutes indicate interest rates are currently appropriate, with potential for cuts in 2026. ...
No comments:
Post a Comment